COR-1004

Corsera Health · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	COR-1004
Sponsor	Corsera Health
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study to Evaluate COR-1004 in Adult Volunteers. (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

COR-1004 CI brief — competitive landscape report
COR-1004 updates RSS · CI watch RSS
Corsera Health portfolio CI